Xoran Technologies announces that it has completed the Phase 1 milestones of the SBIR project, funded by the NIH and NINDS to demonstrate feasibility...
Glaucoma, one of the world's leading causes of irreversible blindness, is expected to affect an estimated 120 million by 2040, globally. Treatment options for...
Inspira Technologies OXY B.H.N. Ltd. (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, following yesterday's announcement of the development of its...
CuePath Innovation and Thirdwayv announced that CuePath has begun volume production of its home-healthcare solution for remote monitoring of patient medication adherence that features...
